Vir Biotechnology (VIR) Tax Provisions (2018 - 2026)

Vir Biotechnology has disclosed Tax Provisions across 9 years of filings, most recently posting $170000.0 for Q1 2026.

• Tax Provisions for Q1 2026 came in at $170000.0, up 962.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $371000.0 (up 126.41% YoY), and the FY2025 annual result was $217000.0, up 118.95% from the prior year.
• Tax Provisions came in at $170000.0 for Q1 2026 at Vir Biotechnology, up from -$137000.0 in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $403.3 million in Q1 2022 to a low of -$157.2 million in Q2 2022.
• The 5-year median for Tax Provisions is -$86000.0 (2024), against an average of $13.2 million.
• Peak annual rise in Tax Provisions reached 205658.16% in 2022, while the deepest fall reached 296756.6% in 2022.
• Vir Biotechnology's Tax Provisions stood at -$50.0 million in 2022, then jumped by 90.44% to -$4.8 million in 2023, then soared by 98.2% to -$86000.0 in 2024, then sank by 59.3% to -$137000.0 in 2025, then soared by 224.09% to $170000.0 in 2026.
• The last three Tax Provisions figures came in at $170000.0 (Q1 2026), -$137000.0 (Q4 2025), and $168000.0 (Q3 2025), per Business Quant data.